Colin Steele
Colin Steele
Verified email at
Cited by
Cited by
CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma
CW Steele, SA Karim, JDG Leach, P Bailey, R Upstill-Goddard, L Rishi, ...
Cancer cell 29 (6), 832-845, 2016
Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis
T Jamieson, M Clarke, CW Steele, MS Samuel, J Neumann, A Jung, ...
The Journal of clinical investigation 122 (9), 3127-3144, 2012
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
BW Miller, JP Morton, M Pinese, G Saturno, NB Jamieson, E McGhee, ...
EMBO molecular medicine 7 (8), 1063-1076, 2015
Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis
R Jackstadt, SR van Hooff, JD Leach, X Cortes-Lavaud, JO Lohuis, ...
Cancer cell 36 (3), 319-336. e7, 2019
Exploiting inflammation for therapeutic gain in pancreatic cancer
CW Steele, NB Jamieson, TRJ Evans, CJ McKay, OJ Sansom, JP Morton, ...
British journal of cancer 108 (5), 997-1003, 2013
Meta-analysis of oral antibiotics, in combination with preoperative intravenous antibiotics and mechanical bowel preparation the day before surgery, compared with intravenous …
ST McSorley, CW Steele, AJ McMahon
BJS open 2 (4), 185-194, 2018
CXCR2 inhibition suppresses acute and chronic pancreatic inflammation
CW Steele, SA Karim, M Foth, L Rishi, JDG Leach, RJ Porter, C Nixon, ...
The Journal of pathology 237 (1), 85-97, 2015
Clinical potential of microRNAs in pancreatic ductal adenocarcinoma
CW Steele, KA Oien, CJ McKay, NB Jamieson
Pancreas 40 (8), 1165-1171, 2011
The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy
CS Reader, S Vallath, CW Steele, S Haider, A Brentnall, A Desai, ...
The Journal of pathology 249 (3), 332-342, 2019
Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic
COVIDSurg Collaborative, JC Glasbey, D Nepogodiev, JFF Simoes, ...
Colorectal Disease 23 (3), 732-749, 2021
Association between preadmission frailty and care level at discharge in older adults undergoing emergency laparotomy
B Carter, J Law, J Hewitt, KL Parmar, JM Boyle, P Casey, I Maitra, ...
Journal of British Surgery 107 (3), 218-226, 2020
Perioperative blood transfusion is associated with postoperative systemic inflammatory response and poorer outcomes following surgery for colorectal cancer
ST McSorley, A Tham, RD Dolan, CW Steele, J Ramsingh, C Roxburgh, ...
Annals of Surgical Oncology 27 (3), 833-843, 2020
Normocytic anaemia is associated with systemic inflammation and poorer survival in patients with colorectal cancer treated with curative intent
ST McSorley, M Johnstone, CW Steele, CSD Roxburgh, PG Horgan, ...
International Journal of Colorectal Disease 34 (3), 401-408, 2019
Targeting inflammation in pancreatic cancer: Clinical translation
CW Steele, NAK Gill, NB Jamieson, CR Carter
World Journal of Gastrointestinal Oncology 8 (4), 380, 2016
The impact of the COVID-19 pandemic on colorectal cancer service provision
Journal of British Surgery 107 (11), e521-e522, 2020
Effect of preoperative oral antibiotics in combination with mechanical bowel preparation on inflammatory response and short-term outcomes following left-sided colonic and …
AM Golder, CW Steele, D Conn, GJ MacKay, DC McMillan, PG Horgan, ...
BJS open 3 (6), 830-839, 2019
Timing is everything: Brca2 and p53 mutations in pancreatic cancer
JP Morton, CW Steele, OJ Sansom
Gastroenterology 140 (4), 1143-1146, 2011
The impact of preoperative systemic inflammation on the efficacy of intravenous iron infusion to correct anaemia prior to surgery for colorectal cancer
ST McSorley, JH Anderson, T Whittle, CS Roxburgh, PG Horgan, ...
Perioperative Medicine 9 (1), 1-9, 2020
Decision‐making for older patients undergoing emergency laparotomy: defining patient and clinician values and priorities
J Law, C Welch, H Javanmard‐Emamghissi, M Clark, CN Bisset, P O’Neil, ...
Colorectal Disease 22 (11), 1694-1703, 2020
KRAS mutations are influential in driving hepatic metastases and predicting outcome in colorectal cancer.
CW Steele, T Whittle, JJ Smith
Chinese Clinical Oncology 8 (5), 53-53, 2019
The system can't perform the operation now. Try again later.
Articles 1–20